
ViaNautis
ViaNautis is transforming cell and gene therapy with polyNaut®, a versatile, non-viral, targeted polymer-based nanovesicles delivery system that enables precise
$25M Series A ·
Source: startupintros.com
Latest round on record: Series A, October 2024, amount undisclosed.
All 2 rounds ↓Signals
ViaNautis | 20 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
- Series A · amount undisclosedSource: fundraisingfox.com
- Series A · $25MSource: startupintros.com
- Website created
Companies like ViaNautis
FFuse Vectors$5M Pre Seed · Feb 2025
RReCode TherapeuticsSeries B+ · Oct 2023LLiberate Bio$31M Seed · Oct 2025
CCarbon CellPre Seed · May 2025WWhiteLab Genomics$26M Series B+ · Oct 2026
TTubulis$360M Series B+ · Oct 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/vianautis (get a free API key).